Regulation of endogenous glucose production after a mixed meal in type 2 diabetes (Q44058308)

29 November 2017

Regulation of endogenous glucose production after a mixed meal in type 2 diabetes (English)

1 reference

29 November 2017

0 references

1 reference

4

Claudio Cobelli

1 reference

29 November 2017

5

Roy Taylor

1 reference

29 November 2017

Parag Singhal

1

1 reference

PubMed ID

12110532

29 November 2017

Andrea Caumo

series ordinal

2

1 reference

PubMed ID

12110532

29 November 2017

Peter E Carey

series ordinal

3

1 reference

29 November 2017

1 August 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

29 November 2017

1 reference

29 November 2017

283

1 reference

29 November 2017

E275-83

1 reference

29 November 2017

2

1 reference

Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog

29 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Mechanisms of fatty acid-induced inhibition of glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Insulin sensitivity and secretion in healthy elderly human subjects with 'abnormal' glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Non-steady state: error analysis of Steele's model and developments for glucose kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Constant specific activity input allows reconstruction of endogenous glucose concentration in non-steady state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

An evaluation of the Deltatrac indirect calorimeter by gravimetric injection and alcohol burning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Pathogenesis of NIDDM. A balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Carbohydrate, fat, and protein metabolism in muscle and in the whole body after mixed meal ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

A Comparison of the Relative Effects of Obesity and Non-insulin-dependent Diabetes Mellitus on In Vivo Insulin-stimulated Glucose Utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Theory of production rate calculations in steady and non-steady states and its application to glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Automated enzymatic determination of plasma free fatty acids by centrifugal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Evidence that insulin can directly inhibit hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Insulin secretion in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Assessment of hepatic insulin action in obese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Glucagon physiology and pathophysiology in the light of new advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2001

10.1152/AJPENDO.00424.2001

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12110532